A Clinical trial to study the safety and efficacy of Chandrakanthi choornam in patients with low sperm count

SAFETY AND EFFICACY OF CHANDRAKANTHI CHOORNAM IN OLIGOSPERMIA â?? A PRECLINICAL AND CLINICAL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/01/004281

Enrollment

Registered

2014-01-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Oligospermia Health Condition 2: N461- Oligospermia

Interventions

Intervention1: Chandrakanthi choornam: Its a Poly herbal formulation 12gm in milk - OD dose Oral route 3 Months - duration Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Married for >1 year Sperm count 1-15 million/ml Normal liver & renal function test Willing to give specimen of semen for before & at the end of the clinical trial Informed patients giving written consent

Exclusion criteria

Exclusion criteria: Azoospermia Aspermia Necrospermia varicocele & hydrocele undescended testis Inguinal hernia Male accessory gland infection Dm/Hypertension/Cardiac Disease Any recent medical or surgical illness Treatment For PromotingSpermatogenetic Fertility In Last 3 Months Other Systemic Disease Requiring Specific Therapies Thyroid Disease Past History Of Renal, Hepatic Or Any Other Chronic Illness In The Patient

Design outcomes

Primary

Measure	Time frame
Sperm count Good above 30 million/ml Moderate 20-30 million/ml Poor No changes Timepoint: Three months	—

Secondary

Measure	Time frame
Impact on the hormonal level due to the clinical trialTimepoint: Three months	—

Countries

India

Contacts

Public ContactDr BAkila

Tamil Nadu Dr.M.G.R Medical University

dr.kmvm@gmail.com9444249798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026